Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Johnson & Johnson (NYSE:JNJ)

102.35
BATS BZX Real-Time Price
As of 1:33pm ET
 +0.38 / +0.37%
Today’s Change
81.79
Today|||52-Week Range
105.49
-0.36%
Year-to-Date
Trending Tickers: DIS, BAC, JNJ, PFE
12:58pm / TheStreet.com
GlaxoSmithKline rules out break up as new drugs boost sales
Feb 03 / FT.com
U.S. Futures Tick Higher as Janet Yellen Worries Over Economy
9:07am / TheStreet.com
Why Medivation, Inc. Shares Crashed 32% in January
Feb 03 / MotleyFool.com
1 Chart That's Bringing Big Smiles to America's Largest Companies
Feb 09 / MotleyFool.com
Oil crash could kill Exxon's perfect AAA rating
Feb 02 / CNNMoney.com
3 Health Care Stocks On The Rise
Feb 08 / TheStreet.com
The 1 Dividend Stock I Want to Own in 2016
Feb 02 / MotleyFool.com
Frontrunning: February 8
Feb 08 / Investing Channel
Top Stocks for Retirees
Feb 02 / MotleyFool.com
Companies Come Under More Pressure to Cut Costs and Boost Share Buybacks
Feb 08 / TheStreet.com
J&J and GSK join Medicxi's European life sciences push
Feb 02 / FT.com
Global currency collapse: Winners and losers
Feb 08 / CNNMoney.com
These Drugs Are Actually Moving The Needle For Johnson & Johnson
Feb 01 / MotleyFool.com
3 Potential Blockbusters Moving the Needle for Big Pharma in 2016
Feb 07 / MotleyFool.com
Why TransEnterix, Inc. Shares Are Soaring Today
Feb 01 / MotleyFool.com
Biogen Inc. Takes Aim at Johnson & Johnson
Feb 07 / MotleyFool.com
Investor calls for big pharma to slim down grow louder
Feb 01 / FT.com
Shares of Incyte Corporation Plummeted in January -- Here's Why
Feb 07 / MotleyFool.com
The Single Best Stock to Own Today
Feb 01 / MotleyFool.com
2 Beaten-Down Biotech Stocks to Buy in February
Feb 06 / MotleyFool.com
The Zacks Analyst Blog Highlights: Caterpillar, McDonald's, 3M, Procter & Gamble and ...
Feb 01 / Zacks.com
If You're in Your 60s, Consider Buying These 3 Stocks
Feb 06 / MotleyFool.com
Lasting lessons for smug CEOs and somnolent shareholders
Feb 01 / FT.com
U.S. exports drop for first time since Great Recession
Feb 05 / CNNMoney.com
Johnson & Johnson Wants Investors to Ignore Falling Hepatitis C Drug Sales
Jan 31 / MotleyFool.com
String of Q4 Earnings Beat Fails to Revive Pharma ETFs
Feb 05 / Zacks.com
J&J (JNJ) Beats on 4Q Earnings but Misses on Revenues
Jan 30 / Zacks.com
Why Isnbt Johnson & Johnson Making More Acquisitions?
Feb 05 / MotleyFool.com
Here's Why Johnson & Johnson's Sales Fell Last Year
Jan 30 / MotleyFool.com
Mass Layoffs To Return With A Vengeance
Feb 04 / Investing Channel
What Johnson & Johnson's Restructuring Means
Jan 30 / MotleyFool.com
2 Numbers in Merck's 4th-Quarter Report That Have Investors Worried
Feb 04 / MotleyFool.com
Dow 30 Stock Roundup: P&G, MCD, JNJ Beat on Earnings; Apple, Boeing, CAT Disappoint
Jan 29 / Zacks.com
Why Achillion Pharmaceuticals Shares Crashed 37% in January
Feb 04 / MotleyFool.com
Johnson & Johnson's Results Include a Healthy Dose of Asterisks
Jan 29 / MotleyFool.com
Smith & Nephew says results prove it can rival big groups
Feb 04 / FT.com
Small Deals to Continue in 2016 for Johnson & Johnson
Jan 29 / MotleyFool.com
Activist investors: hard drugs
Feb 04 / FT.com
Amgen's Q4 Crushed Estimates and Answered 3 Important Questions in the Process
Jan 29 / MotleyFool.com
Activist Investors Are Taking Aim at the Largest Healthcare Company on Earth
Feb 04 / MotleyFool.com
2 Top Stocks to Buy with Dividends Yielding More Than 3%
Jan 28 / MotleyFool.com
Here's How 10 of the Biggest Stock 'Darlings' Did in January
Feb 03 / TheStreet.com
4 Reasons Why Johnson & Johnson Exploded Higher Following Its Q4 Earnings Release
Jan 28 / MotleyFool.com
One Big Threat to Johnson & Johnson's Future
Feb 03 / MotleyFool.com
Caterpillar warns of another difficult year
Jan 28 / FT.com
3 Stocks Pulling The Drugs Industry Downward
Feb 03 / TheStreet.com
J&J Earnings Beat Fails to Cheer Healthcare ETFs
Jan 28 / Zacks.com
Will 2016 Be Amgen Inc.'s Best Year Yet?
Feb 03 / MotleyFool.com
Johnson & Johnson's Newest Billion-Dollar Blockbuster
Jan 28 / MotleyFool.com